Bradley Foster & Sargent’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.6M | Sell |
554,424
-8,670
| -2% | -$931K | 0.93% | 30 |
|
|
2025
Q1 | $56.8M | Sell |
563,094
-15,843
| -3% | -$1.6M | 0.97% | 31 |
|
|
2024
Q4 | $51.7M | Sell |
578,937
-7,271
| -1% | -$649K | 0.87% | 31 |
|
|
2024
Q3 | $49.1M | Sell |
586,208
-82,188
| -12% | -$6.89M | 0.82% | 34 |
|
|
2024
Q2 | $51.5M | Sell |
668,396
-4,234
| -0.6% | -$326K | 0.93% | 33 |
|
|
2024
Q1 | $46.1M | Sell |
672,630
-2,366
| -0.4% | -$162K | 0.83% | 37 |
|
|
2023
Q4 | $39M | Buy |
674,996
+15,718
| +2% | +$909K | 0.76% | 41 |
|
|
2023
Q3 | $35.7M | Hold |
659,278
| – | – | 0.75% | 41 |
|
|
2023
Q2 | $35.7M | Sell |
659,278
-183,886
| -22% | -$9.95M | 0.75% | 41 |
|
|
2023
Q1 | $42.2M | Buy |
843,164
+4,742
| +0.6% | +$237K | 1.01% | 30 |
|
|
2022
Q4 | $38.8M | Buy |
838,422
+2,549
| +0.3% | +$118K | 0.97% | 33 |
|
|
2022
Q3 | $32.4M | Buy |
835,873
+5,178
| +0.6% | +$201K | 0.9% | 35 |
|
|
2022
Q2 | $31M | Sell |
830,695
-8,519
| -1% | -$318K | 0.8% | 42 |
|
|
2022
Q1 | $37.2M | Buy |
+839,214
| New | +$37.2M | 0.79% | 39 |
|